Fortephest
2 known investors
FortePhest is a biotechnology company developing crop protection products, including its development-stage herbicide H-Forte, which uses a new mechanism of action targeting the enzyme Phenylalanine tRNA Synthetase to control both regular and herbicide-resistant weeds. Founded in 2017 and based on research from Cornell University, the Weizmann Institute of Science, and the Hebrew University of Jerusalem, it serves the agricultural crop protection market.
AgTechBiotechClimate Tech
Founders & leadership
DA
Dr. Alex KozakCEO & Co-Founder
PM
Professor Mark SafroCo-Founder & Discovery Director
DI
Dr. Israel ShapiroCo-Founder & Head of Chemistry
RE
Rony EizenshteinCFO
Investors · 2
Frequently asked questions
- What does Fortephest do?
- FortePhest is a biotechnology company developing crop protection products, including its development-stage herbicide H-Forte, which uses a new mechanism of action targeting the enzyme Phenylalanine tRNA Synthetase to control both regular and herbicide-resistant weeds. Founded in 2017 and based on research from Cornell University, the Weizmann Institute of Science, and the Hebrew University of Jerusalem, it serves the agricultural crop protection market.
- Who founded Fortephest?
- Fortephest was founded by Dr. Alex Kozak, Professor Mark Safro, Dr. Israel Shapiro.
- Who are Fortephest's investors?
- Fortephest's investors include Orbia Ventures, SIBF (Southern Israel Bridging Fund) VC.